My 3.5% fall in revenue without hep C and their biggest customer may be wrong, as I don't know if some of their Hep C sales are to Chemist Warehouse, and are therefore doubled up. Which adds to my disdain for their reporting. Very difficult to work out their margins/underlying earnings if CW earnings are removed, which is what I would like to know. Revenues from CW grew at about 4%, SIG ex CW shrank 11%, but Hep C vaccine was a big part of this.
Shorted it after a moments reflection, but a day or two quickie only.
Ann: Sigma 2017/2018 Full Year ASX Release, page-5
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SIG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.91 |
Change
0.050(1.75%) |
Mkt cap ! $2.300B | |||
| Open | High | Low | Value | Volume |
| $2.87 | $2.96 | $2.85 | $24.81M | 8.515M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 146126 | $2.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.91 | 573848 | 8 |
View Market Depth
| Last trade - 16.10pm 03/12/2024 (20 minute delay) ? |
| SIG (ASX) Chart |
